Health Condition 1: J339- Nasal polyp, unspecified
Conditions
Interventions
Intervention1: Lemna Minor 6c: pill form ,30 pill size,oral route administration,6c potency ,first dose at the time of case taking subsequent doses according to follow ups
Control Intervention1: NIL:
Sponsors
Bakson Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Both male and female will be included. Participants diagnosed with nasal polyp Age group of 16 -45years suffering from nasal polyp will be included Participants who will be ready to give consent and assent. Rhinoscopy findings of nasal polyp
Exclusion criteria
Exclusion criteria: Participants on other medication Participants with other upper respiratory tract infections (laryngitis , pharyngitis , diphtheria ,etc) Pregnant and lactating female. Uncontrolled systemic or psychiatric illness Participants with other respiratory infections (chronic bronchitis, bronchial Asthma ,cystic fibrosis Participants with suffering of sinusitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes will be observed on SNOT20 Score Scale Changes can be positive or negative or no changeTimepoint: SNOT20 SCORE Scale will be used at baseline, every 4 weeks upto 24 weeks. 15 month study. 6 months enrolment 6 months follow up 3 months analysis first dose at the time of case taking and subsequent doses according to follow ups. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Rashid Akhtar
Bakson homoeopathic medical college and hospital
Outcome results
None listed